BCAL Diagnostics Balance Sheet Health
Financial Health criteria checks 6/6
BCAL Diagnostics has a total shareholder equity of A$6.1M and total debt of A$543.6K, which brings its debt-to-equity ratio to 9%. Its total assets and total liabilities are A$8.4M and A$2.4M respectively.
Key information
9.0%
Debt to equity ratio
AU$543.58k
Debt
Interest coverage ratio | n/a |
Cash | AU$5.02m |
Equity | AU$6.07m |
Total liabilities | AU$2.36m |
Total assets | AU$8.42m |
Financial Position Analysis
Short Term Liabilities: BDX's short term assets (A$6.3M) exceed its short term liabilities (A$1.2M).
Long Term Liabilities: BDX's short term assets (A$6.3M) exceed its long term liabilities (A$1.1M).
Debt to Equity History and Analysis
Debt Level: BDX has more cash than its total debt.
Reducing Debt: BDX's debt to equity ratio has reduced from 120.6% to 9% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: BDX has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: BDX has sufficient cash runway for 1.2 years if free cash flow continues to reduce at historical rates of 45.4% each year.